Balchem (NASDAQ:BCPC) Issues Earnings Results

Balchem (NASDAQ:BCPC) announced its quarterly earnings results on Thursday. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.25 by ($0.03), Zacks reports. The firm had revenue of $250.52 million for the quarter, compared to analyst estimates of $245.70 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%.

Balchem Price Performance

NASDAQ BCPC opened at $153.64 on Friday. Balchem has a 1 year low of $137.69 and a 1 year high of $186.03. The business’s fifty day moving average is $164.09 and its two-hundred day moving average is $167.19. The stock has a market capitalization of $5.00 billion, a P/E ratio of 39.09, a P/E/G ratio of 4.41 and a beta of 0.75. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on BCPC shares. Sidoti upgraded shares of Balchem to a “hold” rating in a research note on Tuesday, February 25th. HC Wainwright reissued a “buy” rating and set a $190.00 target price on shares of Balchem in a report on Monday, February 24th. Finally, StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.